Sarah Bligh, MD
Gastroenterology · Dakota Dunes, SDNPI 1225266364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 24.9% of the total. That places this record below the midpoint for gastroenterology clinicians in SD, where the typical reported total is $1,171.
Across 80 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$355
- AbbVie$354
- Takeda Pharmaceuticals U.S.A., Inc.$294
- Bristol Myers Squibb$107
- Gilead$68
- Aimmune Therapeutics, Inc.$54
- plus $194 from 7 others
What the payments were for
- Food & beverage$1,39298%
- Education$342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 22 | $355 |
| AbbVie | 23 | $354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $294 |
| Bristol Myers Squibb | 6 | $107 |
| Gilead | 1 | $68 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $49 |
| Celltrion USA Inc. | 3 | $46 |
| Sanofi | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Pfizer | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
How this compares
$1,425 in reported general payments places this provider in the 50th percentile of 41 gastroenterology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf)Adalimumab | 11 | $74,778 |
| LinzessLinaclotide | 102 | $61,025 |
| ViberziEluxadoline | 20 | $32,316 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 380 | $23,984 |
| ZenpepLipase/Protease/Amylase | 13 | $22,636 |
| Dexlansoprazole DrDexlansoprazole | 110 | $20,447 |
| TrulancePlecanatide | 30 | $17,344 |
| Mesalamine | 42 | $14,867 |
| Alosetron Hcl | 27 | $14,529 |
| Lubiprostone | 114 | $8,843 |
| Budesonide DrBudesonide | 56 | $8,066 |
| MotegrityPrucalopride Succinate | 16 | $7,438 |
| Colestipol Hcl | 87 | $6,151 |
| Sucralfate | 86 | $5,584 |
| Budesonide EcBudesonide | 19 | $5,344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf), Linzess, Viberzi | $354 | $168,118133 claims |
| Aimmune Therapeutics, Inc.Zenpep | $54 | $22,63613 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $294 | $7,43816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 41 gastroenterology providers in South Dakota.
Other gastroenterology in Dakota Dunes
- Alexander SarkisianDakota Dunes$26K
- Jeffrey MichalakDakota Dunes$1K
- Michael PersaudDakota Dunes$13
- Chandar SingaramSioux Falls$125K
- Erik NessSioux Falls$50K
- Cristina Hill JensenSioux Falls$49K
- Mouhanna Abu GhanimehSioux Falls$34K
- Muhammad FaisalSioux Falls$30K
- Ali ZakariaRapid City$17K
- Oksana AleksenkoRapid City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.